Cite
HARVARD Citation
Hanzel, J. et al. (n.d.). P344 Effectiveness and safety of switching patients with inflammatory bowel disease from originator infliximab to CT-P13: systematic review and meta-analysis. Journal of Crohn's and colitis. pp. S367-S368. [Online].